Sienna Biopharmaceuticals Inc (SNNA)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Sienna Biopharmaceuticals Inc (SNNA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011366
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sienna Biopharmaceuticals Inc (Sienna Biopharmaceuticals) is a biopharmaceutical company that develops innovation therapies for inflammatory skin conditions and aesthetic conditions. It offers topical by design or low systemic exposure technology platform for local treatment Photoparticle therapy (PPT) platform for treating acne, pigmentation and unwanted hair growth. The company’s pipeline portfolio includes therapies such as SNA 120 for psoriasis and pruritus, SNA 001 for acne vulgaris in phase II stage; and SNA 125 for atopic dermatitis, psoriasis and pruritus in pre-clinical stage; and other therapies in pre-clinical phase. Sienna Biopharmaceuticals is headquartered in Westlake Village, California, the US.

Sienna Biopharmaceuticals Inc (SNNA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Sienna Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Sienna Biopharmaceuticals Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Sienna Biopharma Raises USD40 million in Series B Financing 10
Equity Offering 11
Sienna Biopharma Raises USD74.7 Million in IPO 11
Sienna Biopharma Raises USD0.6 Million in Private Placement of Shares 13
Sienna Biopharmaceuticals Inc – Key Competitors 14
Sienna Biopharmaceuticals Inc – Key Employees 15
Sienna Biopharmaceuticals Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Nov 09, 2017: Sienna Biopharmaceuticals Reports Third Quarter 2017 Financial Results 17
Corporate Communications 18
Dec 12, 2017: Sienna Biopharmaceuticals Establishes Corporate Advisory Board 18
Jun 14, 2017: Sienna Biopharmaceuticals Appoints Erle Mast, Former CFO and Co-Founder of Clovis Oncology, to Board of Directors 19
Mar 24, 2017: Richard Peterson Joins Sienna Biopharmaceuticals As Chief Financial Officer 20
Feb 28, 2017: Former Allergan Chief David Pyott Signs on as Special Advisor to Sienna Biopharmaceuticals 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Sienna Biopharmaceuticals Inc, Medical Equipment, Key Facts 2
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Sienna Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Sienna Biopharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Sienna Biopharma Raises USD40 million in Series B Financing 10
Sienna Biopharma Raises USD74.7 Million in IPO 11
Sienna Biopharma Raises USD0.6 Million in Private Placement of Shares 13
Sienna Biopharmaceuticals Inc, Key Competitors 14
Sienna Biopharmaceuticals Inc, Key Employees 15
Sienna Biopharmaceuticals Inc, Subsidiaries 16

★海外企業調査レポート[Sienna Biopharmaceuticals Inc (SNNA)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Paradigm Biopharmaceuticals Ltd (PAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Paradigm Biopharmaceuticals Ltd (Paradigm Biopharma) is a biopharmaceutical company. The company focused on research and development of therapeutic products for human use. It offers pentosan polysulphate sodium (PPS) drugs for new orthopaedic and respiratory applications. Paradigm Biopharma …
  • LM Wind Power Holding AS:企業の戦略的SWOT分析
    LM Wind Power Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • The People’s Insurance Company (Group) of China Limited:戦略・SWOT・企業財務分析
    The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report Summary The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • Housing Development & Infrastructure Ltd:企業の戦略・SWOT・財務情報
    Housing Development & Infrastructure Ltd - Strategy, SWOT and Corporate Finance Report Summary Housing Development & Infrastructure Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • British Columbia Investment Management Corp:企業の戦略的SWOT分析
    British Columbia Investment Management Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • SMBC Consumer Finance Co Ltd:企業の戦略・SWOT・財務情報
    SMBC Consumer Finance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary SMBC Consumer Finance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • VolitionRX Ltd (VNRX):企業の財務・戦略的SWOT分析
    Summary VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of va …
  • Reviva Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Reviva Pharmaceuticals Inc (Reviva Pharma) is a clinical development pharmaceutical company that develops therapeutic drugs. The company develops drugs in the therapeutic areas of cardiovascular, metabolic, central nervous system and inflammatory diseases. Its product pipeline comprises RP50 …
  • KEB Hana Bank:企業の戦略・SWOT・財務情報
    KEB Hana Bank - Strategy, SWOT and Corporate Finance Report Summary KEB Hana Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Petro Welt Technologies AG (O2C):企業の財務・戦略的SWOT分析
    Petro Welt Technologies AG (O2C) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Airservices Australia:企業の戦略的SWOT分析
    Airservices Australia - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • CDI Corp:企業の戦略的SWOT分析
    CDI Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Hindustan Petroleum Corporation Limited:企業の戦略・SWOT・財務分析
    Hindustan Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Hindustan Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Singularlogic Information Systems And Software Technology S.A.:企業の戦略的SWOT分析
    Singularlogic Information Systems And Software Technology S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees …
  • WCCT Global Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary WCCT Global Inc (WCCT Global) is a contract research organization that offers early drug development and late phase CRO services. The organization provides CRO solutions, clinical development and clinical support services. Its CRO solutions include project management, clinical monitoring, ph …
  • Big Rivers Electric Corporation:発電所・企業SWOT分析
    Big Rivers Electric Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Spirit AeroSystems Holdings, Inc.:企業のM&A・事業提携・投資動向
    Spirit AeroSystems Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Spirit AeroSystems Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • RockBridge Resources Inc (RBE):石油・ガス:M&Aディール及び事業提携情報
    Summary RockBridge Resources Inc (RockBridge) is an oil and gas exploration and development company. The company acquires, develops and explores oil and gas properties. Its properties include Twinning area, Open Creek property, Pembina and Brazeau property, and Bigoray area of Alberta. RockBridge’s …
  • Family Dollar Stores, Inc.:企業の戦略・SWOT・財務情報
    Family Dollar Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Family Dollar Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • The Siam Cement Public Co Ltd:企業の戦略・SWOT・財務分析
    The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆